Key result
Frailty affects up to 79% of patients with heart failure and is associated with reduced quality of life and poor prognosis, making it a key factor in waitlisting for heart transplantation.
Why the study?
Frailty is increasingly recognized in cardiovascular disease, affecting up to 79% of patients with heart failure and associating with reduced quality of life and poor prognosis.
Frailty is highly prevalent in heart failure and plays a key role in the evaluation and waitlisting of patients for heart transplantation.
Answers are grounded in this paper and cite their sources.
Supports frailty assessment in heart transplant waitlisting; hypothesis-generating pending prospective validation.
The role of frailty in cardiovascular disease is becoming increasingly recognized. Up to 79% of patients with heart failure are frail. Frailty is associated with reduced quality of life and poor prognosis. This review summarizes the available literature on frailty and its key role in waitlisting patients for heart transplantation.
No takes yet. Share an insight, caveat, or question.
Колоскова et al. (2022) studied this question. Frailty affects up to 79% of patients with heart failure and is associated with reduced quality of life and poor prognosis, making it a key factor in waitlisting for heart transplantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: